<DOC>
	<DOC>NCT00922467</DOC>
	<brief_summary>Main objective is to evaluate the sparing effect of esmolol on the required doses of propofol and remifentanil</brief_summary>
	<brief_title>Influence of Esmolol on a Closed-Loop Anesthesia System</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Esmolol</mesh_term>
	<criteria>male patients scheduled for a general anesthesia age lower than 18 years allergy to propofol, or to soja or to peanuts, or to sufentanil, to remifentanil, or to morphine, or to a myorelaxant or to an excipient, any other history of anaphylactic reaction, hypersensibility to sufentanil, or to remifentanil, or to other derivate of fentanyl, hypersensibility to esmolol or to an excipient, history of central nervous system disease, patients receiving a psychotropic treatment or an agonistantagonist opiate, hypovolemic patients, patients receiving a cardiovascular treatment, patients with a pacemaker, expected bleeding more than 20% of the blood volume, simultaneous general and locoregional anesthesia, patients suffering from asthma, COPD, trouble of the heart rhythm or conduction, cardiac insufficiency, cardiogenogenic shock, Prinzmetal syndrome, pheochromocytoma, patients with a heart rate less than 50/min and/or an arterial hypotension, neurosurgical act or any other which precludes an adequate positioning of the bispectral electrode.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>